M. Angi, H. Kalirai, S. Prendergast, D. Simpson, D. E. Hammond et al., In-depth proteomic profiling of the uveal melanoma secretome, Oncotarget, vol.7, pp.49623-49635, 2016.

N. Babchia, A. Calipel, F. Mouriaux, A. M. Faussat, and F. Mascarelli, 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines, Investigative Ophthalmology & Visual Science, vol.49, pp.2348-2356, 2008.

G. Barisione, M. Fabbi, A. Gino, P. Queirolo, L. Orgiano et al., Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma, JAMA Ophthalmology, vol.133, pp.1013-1021, 2015.

,

D. J. Brat, A. C. Bellail, and E. G. Van-meir, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis, Neuro-Oncology, vol.7, pp.122-133, 2005.

I. H. Bronkhorst and M. J. Jager, Uveal melanoma: the inflammatory microenvironment, Journal of Innate Immunity, vol.4, pp.454-462, 2012.

I. H. Bronkhorst and M. J. Jager, Inflammation in uveal melanoma, Eye, vol.27, pp.217-223, 2013.

A. Calipel, V. Abonnet, O. Nicole, F. Mascarelli, S. E. Coupland et al., Status of RASSF1A in uveal melanocytes and melanoma cells, Molecular Cancer Research, vol.9, pp.1187-1198, 2011.

,

H. Cheng, V. Chua, C. Liao, T. J. Purwin, M. Terai et al., Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma, Molecular Cancer Therapeutics, vol.16, pp.516-528, 2017.

U. Coskun, N. Bukan, B. Sancak, N. Gunel, S. Ozenirler et al., Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions, Neoplasma, vol.51, pp.209-213, 2004.

C. Coulouarn, A. Corlu, D. Glaise, I. Guenon, S. S. Thorgeirsson et al., Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma, Cancer Research, vol.72, pp.2533-2542, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00864206

C. Coulouarn, V. M. Factor, J. B. Andersen, M. E. Durkin, and S. S. Thorgeirsson, Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, 2009.

, Oncogene, vol.28, pp.3526-3536

M. A. Economou, C. All-ericsson, V. Bykov, L. Girnita, A. Bartolazzi et al., Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications, Acta Ophthalmology. 86 Thesis, vol.4, pp.20-25, 2008.

K. G. Griewank, X. Yu, J. Khalili, M. M. Sozen, K. Stempke-hale et al., Genetic and molecular characterization of uveal melanoma cell lines, Pigment Cell Melanoma Res, vol.25, pp.182-187, 2012.

H. E. Grossniklaus, Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture, JAMA Ophthalmology, vol.131, pp.462-469, 2013.

H. E. Grossniklaus, Q. Zhang, S. You, C. Mccarthy, S. Heegaard et al., Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns, Hum Pathol, vol.57, pp.165-175, 2016.

,

S. Herbertz, J. S. Sawyer, A. J. Stauber, I. Gueorguieva, K. E. Driscoll et al., Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway, Drug Des Devel Ther, vol.9, pp.4479-4499, 2015.

L. J. Ho, S. F. Luo, and J. H. Lai, Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers, Biochemical Pharmacology, vol.97, pp.16-26, 2015.

K. Inoue, J. W. Slaton, S. J. Kim, P. Perrotte, B. Y. Eve et al., Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer, Cancer Research, vol.60, pp.2290-2299, 2000.

H. Jiang, J. Lin, Z. Z. Su, M. Herlyn, R. S. Kerbel et al., The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells, Oncogene, vol.10, pp.1855-1864, 1995.

C. Johnson, Y. Han, N. Hughart, J. Mccarra, G. Alpini et al., Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer, Translational Gastrointestinal Cancer, vol.1, pp.58-70, 2012.

,

Y. Krishna, C. Mccarthy, H. Kalirai, and S. E. Coupland, Inflammatory cell infiltrates in advanced metastatic uveal melanoma, Hum Pathol, vol.66, pp.159-166, 2017.

B. Lafoya, J. A. Munroe, A. Miyamoto, M. A. Detweiler, J. J. Crow et al., Beyond the Matrix: The Many Non-ECM Ligands for Integrins, Int J Mol Sci, vol.19, 2018.

S. Landreville, O. A. Agapova, and J. W. Harbour, Emerging insights into the molecular pathogenesis of uveal melanoma, Future Oncology, vol.4, pp.629-636, 2008.

J. M. Lattier, H. Yang, S. Crawford, and H. E. Grossniklaus, Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma, Clinical and Experimental Metastasis, vol.30, pp.969-976, 2013.

V. G. Likhvantseva, O. S. Slepova, and V. A. Gerasimenko, , 1997.

, Vestnik Oftalmologii, vol.113, pp.39-41

F. Mbeunkui, D. J. Johann, and . Jr, Cancer and the tumor microenvironment: a review of an essential relationship, Cancer Chemotherapy and Pharmacology, vol.63, pp.571-582, 2009.

S. Moretti, A. Chiarugi, F. Semplici, A. Salvi, V. De-giorgi et al., Serum imbalance of cytokines in melanoma patients, Melanoma Research, vol.11, pp.395-399, 2001.

F. Mouriaux, F. Casagrande, M. J. Pillaire, S. Manenti, F. Malecaze et al., Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes, Investigative Ophthalmology & Visual Science, vol.39, pp.876-884, 1998.

F. Mouriaux, C. A. Maurage, P. Labalette, B. Sablonniere, F. Malecaze et al., Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors, Investigative Ophthalmology & Visual Science, vol.41, pp.2837-2843, 2000.

F. Mouriaux, V. Servois, J. J. Parienti, T. Lesimple, A. Thyss et al., Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study, British Journal of Cancer, vol.115, pp.20-24, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01576007

F. Mouriaux, K. Zaniolo, M. A. Bergeron, C. Weidmann, A. De-la-fouchardiere et al., Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors, Investigative Ophthalmology & Visual Science, vol.57, pp.5288-5301, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01481461

N. Nishimoto, Y. Kanakura, K. Aozasa, T. Johkoh, M. Nakamura et al., Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease, Blood, vol.106, pp.2627-2632, 2005.

Y. Qin, M. Petaccia-de-macedo, A. Reuben, M. A. Forget, C. Haymaker et al., Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study, Oncoimmunology, vol.6, 2017.

A. Rizwan, M. Cheng, Z. M. Bhujwalla, B. Krishnamachary, L. Jiang et al., Breast cancer cell adhesome and degradome interact to drive metastasis, NPJ Breast Cancer, vol.1, 2015.

J. F. Rossi, Z. Y. Lu, M. Jourdan, and B. Klein, Interleukin-6 as a therapeutic target, Clinical Cancer Research, vol.21, pp.1248-1257, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02137928

K. Sato, M. Tsuchiya, J. Saldanha, Y. Koishihara, Y. Ohsugi et al., Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth, Cancer Research, vol.53, pp.851-856, 1993.

A. D. Singh, L. Bergman, and S. Seregard, Uveal melanoma: epidemiologic aspects, Ophthalmology Clinics of North America, vol.18, pp.75-84, 2005.
DOI : 10.1007/978-3-642-54255-8_6

A. D. Singh, M. E. Turell, and A. K. Topham, Uveal melanoma: trends in incidence, treatment, and survival, Ophthalmology, vol.118, pp.1881-1885, 2011.
DOI : 10.1016/j.ophtha.2011.01.040

Y. Teng, J. L. Ross, and J. K. Cowell, The involvement of JAK-STAT3 in cell motility, invasion, and metastasis, 2014.

T. Ueda, E. Shimada, and T. Urakawa, Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis, Journal of Gastroenterology, vol.29, pp.423-429, 1994.

D. J. Verbik, T. G. Murray, J. M. Tran, and B. R. Ksander, Melanomas that develop within the eye inhibit lymphocyte proliferation, International Journal of Cancer, vol.73, pp.470-478, 1997.

F. Vidal-vanaclocha, The prometastatic microenvironment of the liver, Cancer Microenvironment, vol.1, pp.113-129, 2008.

K. Xie, Interleukin-8 and human cancer biology, Cytokine & Growth Factor Reviews, vol.12, pp.375-391, 2001.

L. Xu, A. Y. Hui, E. Albanis, M. J. Arthur, S. M. O'byrne et al., Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, Gut, vol.54, pp.142-151, 2005.

C. Yin, K. J. Evason, K. Asahina, and D. Y. Stainier, Hepatic stellate cells in liver development, regeneration, and cancer, Journal of Clinical Investigation, vol.123, pp.1902-1910, 2013.

M. C. Yu, C. H. Chen, X. Liang, L. Wang, C. R. Gandhi et al., Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice, Hepatology, vol.40, pp.1312-1321, 2004.

(. , 3 (white) and Mel270 (black) were grown alone or cocultured with LX-2 cells. B. LX-2 cells were grown alone or co-cultured with OMM2.3 (white) or Mel270 (black) cells. C. OMM2.3 (white) and Mel270 (black) were grown alone or co-cultured with LX-2 cells. D. LX-2 cells were grown alone or co-cultured with OMM2.3 (white) or Mel270 (black) cells. Transcripts listed in A to D were selected on the basis of the significance for their differential expression in monoculture versus co-culture conditions

, Quantitative analysis of the expression of integrin transcripts in co-cultures of UMCs and HSCs

, The quantification is presented as percentage of relative expression in grayscale, where the largest value appears in black (100%), and the smallest value in white (0%). B. LX-2 cells were grown alone or in coculture with UMCs (LX-2/Mel270, LX-2/OMM2.3). C. Mel270 and OMM2.3 cells were grown alone or cocultured with HSCs (Mel270/LX-2, OMM2.3/LX-2). Total RNA was harvested after 48 hours and the expression of integrins ITGA1, A. Heatmap of the relative expression of alpha and beta integrin subunits in LX-2 cells and UMCs grown alone or in co-culture

, Total proteins from Mel270, OMM2.3, and LX-2 cells grown alone or in co-culture conditions (Mel270/LX-2, OMM2.3/LX-2, LX-2/Mel270, LX-2/OMM2.3) and treated with TCZ were harvested after 48 hours. The expression of phosphor-STAT3 and total STAT3 was quantified by Western blotting (?-Actin, control loading). B-D. Cell proliferation was measured 48 hours post-TCZ treatment using the MTT colorimetric assays. E-H. Total RNA from Mel270, OMM2.3 and LX-2 cells grown alone or in co-culture conditions